Correlation Between Silo Pharma and Encore Capital
Can any of the company-specific risk be diversified away by investing in both Silo Pharma and Encore Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silo Pharma and Encore Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Silo Pharma and Encore Capital Group, you can compare the effects of market volatilities on Silo Pharma and Encore Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silo Pharma with a short position of Encore Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silo Pharma and Encore Capital.
Diversification Opportunities for Silo Pharma and Encore Capital
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Silo and Encore is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Silo Pharma and Encore Capital Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Encore Capital Group and Silo Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silo Pharma are associated (or correlated) with Encore Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Encore Capital Group has no effect on the direction of Silo Pharma i.e., Silo Pharma and Encore Capital go up and down completely randomly.
Pair Corralation between Silo Pharma and Encore Capital
Given the investment horizon of 90 days Silo Pharma is expected to generate 4.61 times more return on investment than Encore Capital. However, Silo Pharma is 4.61 times more volatile than Encore Capital Group. It trades about 0.03 of its potential returns per unit of risk. Encore Capital Group is currently generating about 0.02 per unit of risk. If you would invest 149.00 in Silo Pharma on September 3, 2024 and sell it today you would lose (49.00) from holding Silo Pharma or give up 32.89% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Silo Pharma vs. Encore Capital Group
Performance |
| Timeline |
| Silo Pharma |
| Encore Capital Group |
Silo Pharma and Encore Capital Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Silo Pharma and Encore Capital
The main advantage of trading using opposite Silo Pharma and Encore Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silo Pharma position performs unexpectedly, Encore Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Encore Capital will offset losses from the drop in Encore Capital's long position.| Silo Pharma vs. Protagenic Therapeutics | Silo Pharma vs. Rezolute | Silo Pharma vs. Lumos Pharma | Silo Pharma vs. Anebulo Pharmaceuticals |
| Encore Capital vs. Guild Holdings Co | Encore Capital vs. Mr Cooper Group | Encore Capital vs. CNFinance Holdings | Encore Capital vs. Security National Financial |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |